Search Results - Tai, Keen Hun, FRANZCR

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial

    Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial by Denham, James W, Prof, Steigler, Allison, BMath, Lamb, David S, Prof, Joseph, David, Prof, Turner, Sandra, FRANZCR, Matthews, John, FRANZCR, Atkinson, Chris, FRANZCR, North, John, FRANZCR, Christie, David, FRANZCR, Spry, Nigel A, Prof, Tai, Keen-Hun, FRANZCR, Wynne, Chris, FRANZCR, D'Este, Catherine, Prof

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial

    Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prost... by Denham, James W, Prof, Joseph, David, Prof, Lamb, David S, Prof, Spry, Nigel A, Prof, Duchesne, Gillian, Prof, Matthews, John, FRANZCR, Atkinson, Chris, FRANZCR, Tai, Keen-Hun, FRANZCR, Christie, David, Prof, Kenny, Lizbeth, FRANZCR, Turner, Sandra, FRANZCR, Gogna, Nirdosh Kumar, FRANZCR, Diamond, Terry, Prof, Delahunt, Brett, Prof, Oldmeadow, Christopher, PhD, Attia, John, Prof, Steigler, Allison, BMath

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

    Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 tri... by Duchesne, Gillian M, Prof, Woo, Henry H, MB BS, Bassett, Julie K, PhD, Bowe, Steven J, PhD, D'Este, Catherine, Prof, Frydenberg, Mark, MB BS, King, Madeleine, Prof, Ledwich, Leo, Loblaw, Andrew, Prof, Malone, Shawn, FRCPC, Millar, Jeremy, FRANZCR, Milne, Roger, PhD, Smith, Rosemary G, GradDip, Spry, Nigel, Prof, Stockler, Martin, Prof, Syme, Rodney A, FRACS, Tai, Keen Hun, FRANZCR, Turner, Sandra, MB BS

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial

    Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from... by Denham, James W, Prof, Wilcox, Chantelle, GradDipClinEpi, Joseph, David, Prof, Spry, Nigel A, Prof, Lamb, David S, Prof, Tai, Keen-Hun, FRANZCR, Matthews, John, FRANZCR, Atkinson, Chris, FRANZCR, Turner, Sandra, FRANZCR, Christie, David, FRANZCR, Gogna, Nirdosh Kumar, FRANZCR, Kenny, Lizbeth, FRANZCR, Duchesne, Gillian, Prof, Delahunt, Brett, Prof, McElduff, Patrick, PhD

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial

    Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled tri... by Denham, James W, Prof, Steigler, Allison, BMath, Wilcox, Chantelle, BBiomedSc, Lamb, David S, FRANZCR, Joseph, David, Prof, Atkinson, Chris, FRANZCR, Matthews, John, FRANZCR, Tai, Keen-Hun, FRANZCR, Spry, Nigel A, Prof, Christie, David, FRANZCR, Gleeson, Paul S, Greer, Peter B, PhD, D'Este, Catherine, Prof

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: